These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 18784381)

  • 1. Natalizumab for multiple sclerosis?
    Drug Ther Bull; 2008 Sep; 46(9):69-72. PubMed ID: 18784381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natalizumab: alpha 4-integrin antagonist selective adhesion molecule inhibitors for MS.
    Rudick RA; Sandrock A
    Expert Rev Neurother; 2004 Jul; 4(4):571-80. PubMed ID: 15853576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natalizumab (Tysabri) for relapsing multiple sclerosis.
    Med Lett Drugs Ther; 2005 Feb; 47(1202):13-5. PubMed ID: 15711498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natalizumab (Tysabri) treatment for relapsing multiple sclerosis.
    Johnson KP
    Neurologist; 2007 Jul; 13(4):182-7. PubMed ID: 17622909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selective adhesion molecule inhibitors. Natalizumab in multiple sclerosis and Crohn's disease].
    Hennemann A
    Med Monatsschr Pharm; 2003 May; 26(5):146-8. PubMed ID: 12784500
    [No Abstract]   [Full Text] [Related]  

  • 6. Natalizumab (Tysabri) returns.
    Med Lett Drugs Ther; 2006 Sep; 48(1243):76. PubMed ID: 16977289
    [No Abstract]   [Full Text] [Related]  

  • 7. Blocking adhesion molecules as therapy for multiple sclerosis: natalizumab.
    Steinman L
    Nat Rev Drug Discov; 2005 Jun; 4(6):510-8. PubMed ID: 15931259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natalizumab: new drug. Multiple sclerosis: risky market approval.
    Prescrire Int; 2008 Feb; 17(93):7-10. PubMed ID: 18354844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of natalizumab in the treatment of multiple sclerosis.
    Coyle PK
    Am J Manag Care; 2010 Jun; 16(6 Suppl):S164-70. PubMed ID: 20615052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple sclerosis and Natalizumab.
    Fiore D
    Am J Ther; 2007; 14(6):555-60. PubMed ID: 18090880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical evaluation of natalizumab for formulary consideration.
    Bivins A; Hou K; Ayesu N; Ellsworth B; Montenegro S; Tu X; Boyle C; Dowling T; Shaya FT
    Expert Opin Biol Ther; 2010 Aug; 10(8):1279-87. PubMed ID: 20626228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment: the use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
    Goodin DS; Cohen BA; O'Connor P; Kappos L; Stevens JC;
    Neurology; 2008 Sep; 71(10):766-73. PubMed ID: 18765653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe relapses after the first infusion of natalizumab in active relapsing-remitting multiple sclerosis.
    Rinaldi F; Perini P; Calabrese M; Rinaldi L; Gallo P
    Mult Scler; 2009 Nov; 15(11):1359-62. PubMed ID: 19812116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natalizumab for relapsing-remitting multiple sclerosis.
    Horga A; Tintoré M
    Neurologia; 2011; 26(6):357-68. PubMed ID: 21193250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective treatment of multiple sclerosis.
    Ropper AH
    N Engl J Med; 2006 Mar; 354(9):965-7. PubMed ID: 16510751
    [No Abstract]   [Full Text] [Related]  

  • 16. Natalizumab for multiple sclerosis.
    Ransohoff RM
    N Engl J Med; 2007 Jun; 356(25):2622-9. PubMed ID: 17582072
    [No Abstract]   [Full Text] [Related]  

  • 17. [Natalizumab (Tysabri) prescription practices of neurologists in southern France].
    Rocher F; Cohen M; Lebrun C
    Rev Neurol (Paris); 2010 Apr; 166(4):412-8. PubMed ID: 19846185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale.
    Rice GP; Hartung HP; Calabresi PA
    Neurology; 2005 Apr; 64(8):1336-42. PubMed ID: 15851719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natalizumab. Elan/Biogen.
    Elices MJ
    Curr Opin Investig Drugs; 2003 Nov; 4(11):1354-62. PubMed ID: 14758775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natalizumab for the treatment of multiple sclerosis and Crohn's disease.
    Keeley KA; Rivey MP; Allington DR
    Ann Pharmacother; 2005 Nov; 39(11):1833-43. PubMed ID: 16219898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.